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ABSTRACT
We describe an inexpensive and efficient method for
generating functional pools of Dicer-substrate small
interfering RNAs (siRNAs) in a single reaction tube.
The method exploits a highly active form of the
enzyme Dicer from Giardia lamblia, which is
capable of accurately processing double-stranded
RNA (dsRNA) into 25–27nt RNA pools during
in vitro transcription. The small RNAs produced
function as substrates of human Dicer in vitro and
induce gene silencing with potency equivalent to
traditional siRNAs when introduced into mammalian
cells. The overall reaction is simple, can be carried
out in any laboratory with access to a PCR machine,
and is amenable to high-throughput processes.
INTRODUCTION
The use of small interfering RNAs (siRNAs) to
knockdown speciﬁc gene sequences is a powerful tool
for reverse-genetic experiments in a variety of mammalian
cell types (1). However, siRNAs are costly to synthesize,
and potent siRNA sequences, with minimal off-target
effects, are often best identiﬁed experimentally. To
overcome these limitations, several groups have developed
enzymatic methods for generating pools of siRNAs
against a chosen target gene (2,3). siRNA pools are
believed to be less susceptible to off-target effects, as no
single siRNA sequence is present in high abundance (4).
Typically, protocols for generating siRNA pools involve
transcription of the target gene into forward and reverse
strand RNAs, followed by puriﬁcation and annealing to
form dsRNA. Alternatively, puriﬁed single stranded RNA
can be treated with an RNA dependent RNA polymerase
to generate long dsRNA (5). Long dsRNAs are then
cleaved into small RNA fragments using either recombin-
ant human Dicer or bacterial RNase III enzymes. These
methods have been used by many groups for generating
functional pools of small RNAs (6–10). However, the es-
tablished protocols employ multiple discrete steps and are
relatively time-consuming.
We have developed a simpliﬁed method for generating
siRNA pools that can be carried out in a single reaction
tube. The method takes advantage of a Dicer homolog
from the protozoan Giardia lamblia, which cleaves long
dsRNA substrates into small RNAs 25-27nt in length
(11). Because Giardia Dicer is highly active in a wide
range of reaction conditions, it can be included in the
dsRNA transcription reaction. DNA templates for the
transcription can be taken directly from PCRs without
further clean-up. Therefore, the entire reaction, starting
with the cDNA clone of a target gene and gene-speciﬁc
PCR primers, and ending with a pool of siRNAs
against the target, can be carried out with very little
manipulation of the sample. The small RNAs produced
are substrates for human Dicer, which cleaves them into
siRNAs 20–23nt in length, and promote sequence speciﬁc
silencing of target genes when introduced into mammalian
cells.
METHODS AND MATERIALS
Protein expression and puriﬁcation
Giardia Dicer (XP_001705536) was produced and puriﬁed
from a baculovirus expression system. The plasmid
pFB-GiDcr, which contains the Giardia Dicer coding
region cloned into pFastBac HTA (Invitrogen), was used
to generate baculovirus using the Bac-to-Bac method
(Invitrogen). For protein expression, 250ml of Sf9 cells
(1 10
6 cells per ml) were grown at 27 C in ESF 921
media (Expression Systems, Woodland, CA, USA) and
infected with 0.5ml of ampliﬁed baculovirus bearing the
Giardia Dicer gene. Forty-eight to seventy-two hours after
infection, cells were pelleted by centrifugation and resus-
pended in 5ml of a lysis buffer composed of 300mM
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phosphine (TCEP), 0.5% Triton X-100 and 50mM
sodium phosphate, pH 8. Resuspended cells were lysed
with seven strokes of a Dounce tissue grinder and then
centrifuged to pellet insoluble material. The soluble cell
lysate was then applied to 3ml of HIS-Select nickel
chelate resin (Sigma) in batch. After a 30min incubation
period, the HIS-Select resin was pelleted by centrifugation
and the unbound supernatant ﬂuid was discarded. The
resin was washed by resuspending in 50ml of a wash
buffer containing 300mM NaCl, 20mM imidazole,
0.5mM TCEP and 50mM sodium phosphate, pH 8 and
then pelleted again by centrifugation. The wash step was
repeated a total of ﬁve times. The protein was then eluted
from the resin in 9ml of an elution buffer composed of:
300mM NaCl, 300mM imidazole, 0.5mM TCEP, 50mM
sodium phosphate, pH 8. Eluted protein was dialyzed
overnight against 0.1M NaCl, 10% glycerol, 1mM
TCEP and 40mM Tris, pH 8. The dialyzed protein was
concentrated to 0.5mg/ml. During the ﬁnal concentration
steps the protein was exchanged into a protein storage
buffer composed of 50% glycerol, 0.1M NaCl, 1mM
TCEP and 40mM Tris, pH 8. All puriﬁcation steps were
carried out on ice or at 4 C. The ﬁnal puriﬁed protein was
stored at  80 C at 0.5mg/ml in the storage buffer.
Recombinant human Dicer (NM_030621) was ex-
pressed and puriﬁed as described previously (11,12).
Puriﬁed human Dicer can be stored in the same storage
buffer as Giardia Dicer (above). T7 RNA polymerase was
expressed in Escherichia coli strain BL21(DE3) and
puriﬁed as described (13). E. coli RNase III was purchased
from New England Biolabs (M0245S).
Transcription/dicing reaction
Templates for in vitro transcription were generated by
amplifying a  500 base-pair segment of the desired
target gene in a PCR (30 cycles) using Taq DNA polymer-
ase (New England Biolabs, M0273S) or Pfu Turbo DNA
polymerase (Agilent, 600254-52). PCR primers contained
the promoter sequence for T7 RNA polymerase (TAATA
CGACTCACTATAG) on their 50-ends, allowing
ampliﬁed DNA to be transcribed in both directions in
the subsequent transcription/dicing reaction.
A5 ml aliquot of the PCR was used directly, without
puriﬁcation, in a 100ml transcription/dicing reaction con-
taining: 10mM DTT, 10mM MgCl2, 2mM ATP, 2mM
CTP, 2mM GTP, 2mM UTP, 1mg/ml T7 RNA polymer-
ase, 20ng/ml Giardia Dicer, and 40mM Tris, pH 8.
Transcription/dicing reactions were incubated at 37 C
for 2–3h. The 20ng/ml of puriﬁed Giardia Dicer could
be replaced with 8ml of the commercially available
‘PowerCut’ Giardia Dicer (Fisher Scientiﬁc, F602S).
However, the PowerCut enzyme had signiﬁcantly less
activity than our puriﬁed Giardia Dicer and thus reactions
using PowerCut Dicer required a much longer incubation
time (16h at 37 C). The DNA template and any remaining
single-stranded RNA were then degraded by adding 1ml
DNase I (New England Biolabs, M03035S) and 1ml
RNase T1 (Roche, 10-109-193-001) and incubating an
additional 15–30min at 37 C. Enzymes were removed by
extracting with 100ml phenol/chloroform/isoamyl alcohol
(25:24:1, pH 6.7). The aqueous layer was transferred to a
new tube where RNA was precipitated by adding 10mlo f
3M sodium acetate (pH 5.2) and 250ml of 100% ethanol.
After centrifugation, the pelleted RNA was washed with
1ml of 70% ethanol and then dissolved in 50ml of water.
At this stage of the preparation the small RNAs could be
transfected directly into mammalian cells. However,
residual unincorporated nucleotides were often still
present and interfered with accurate RNA concentration
measurement. Unincorporated nucleotides were removed
by passing the sample through an illustra MicroSpin G-25
column (GE Healthcare Biosciences). RNA concentration
was determined by UV spectroscopy.
Small RNA pools generated by human Dicer or bacter-
ial RNase III were prepared as described previously (2,3).
In vitro human Dicer cleavage assays
A radiolabeled small RNA pool against ﬁreﬂy luciferase
was generated by including a-
32P-UTP in a transcription/
dicing reaction. Small RNAs were puriﬁed on a native
polyacrylamide gel (14%) in 0.5x TBE buffer. Puriﬁed
small RNAs were incubated with 3.3mg of puriﬁed
human Dicer in a buffer solution containing 150mM
NaCl, 20mM Tris pH 8.0, 2mM MgCl2, 0.5mM TCEP
and incubated at 37 C for  90min. Diced products were
precipitated, resolved on by denaturing PAGE (14%) and
imaged by phosphorimaging.
Cell culture, transfection and luciferase assays
HeLa, HEK 293 FT and NIH 3T3 cells were grown in
DMEM (Gibco) supplemented with 10% fetal bovine
serum (Lonza) and antibiotic-antimycotic (Gibco) at
37 C under a 5% CO2 atmosphere. The day before trans-
fection, cells were plated onto 24-well dishes to  60%
conﬂuency. Plasmids and siRNA were transfected into
cells using Lipofectamine 2000 (Invitrogen), according to
the manufacture’s instructions. Small RNA pools target-
ing ﬁreﬂy luciferase (derived from nucleotides 347-868 of
pIS0, Addgene plasmid 12178,) were transfected with
83ng of pIS0 (14), and 17ng of pIS2 (Addgene plasmid
12177), which encodes Renilla luciferase (15) in each well
of a 24-well dish. Luciferase activity from cell lysates was
measured 24h post-transfection using the Dual Luciferase
Assay system (Promega) on a 20/20n luminometer
(Turner Biosystems).
PME-1 knock-down
HEK 293 cells were plated in 6-well dishes and transfected
with 100pmol (33nM, ﬁnal concentration) of a small
RNA pool targeting nucleotides 420–967 of the human
PME-1 gene (NM_016147) using Lipofectamine 2000
(Invitrogen). 100pmol of a synthetic siRNA targeting nu-
cleotides 153–171 was transfected as a positive control for
PME-1 knock-down. Untransfected cells and cells trans-
fected with 100pmol of a small RNA pool targeting
Renilla luciferase served as negative controls. 48h after
transfection, cells were washed and resuspended in 500ml
of DPBS (Gibco). Cells were disrupted by sonication and
denatured with 4  SDS/PAGE loading buffer (reducing).
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analyzed by western blotting using standard methods.
PME-1 antibodies were purchased from Millipore
(07-095). Blots were probed following the manufacturers’
instructions, and were visualized and quantiﬁed using the
Odyssey Imaging System (Li-Cor).
RESULTS AND DISCUSSION
Giardia Dicer can generate small RNAs during in vitro
transcription
Previous methods for generating siRNA pools involve
multiple discrete steps including transcription, RNA puri-
ﬁcation, annealing and long dsRNA cleavage steps.
However, in living cells all of these processes occur simul-
taneously and thus, in principle, the entire reaction should
be able to be carried out in vitro in a single reaction tube.
To explore this idea we tested different RNases for the
ability to efﬁciently cleave a 500bp dsRNA into siRNAs
during in vitro transcription by T7 RNA polymerase.
Recombinant human Dicer has been used to success-
fully generate siRNA pools from puriﬁed long dsRNA
(2). However, we found human Dicer is unable to match
the pace of transcription in vitro, even when high enzyme
concentrations are used, and converts only a small
fraction of the dsRNA into siRNAs (Figure 1A). This is
most likely due to the enzyme’s poor catalytic efﬁciency
and susceptibility to product inhibition (16,17). Bacterial
RNase III has also been used to generate siRNA pools (3)
and, in contrast to human Dicer, this enzyme does efﬁ-
ciently convert dsRNA into small RNAs during in vitro
transcription. However, RNase III lacks the precision of
Dicer and generates a pool of small RNAs ranging from
30nt down to less than 10 nucleotides in length, with the
most abundant species being about 9nt. In titration
experiments we were unable the ﬁnd a concentration of
RNase III that could reliably convert a long dsRNA into a
 21nt pool during in vitro transcription (Supplementary
Figure S1).
We next examined the ability of Dicer from the proto-
zoan Giardia lamblia to process long dsRNA into siRNAs
during in vitro transcription. The Giardia enzyme is a small
and simpliﬁed form of Dicer that is missing many of the
accessory domains found in Dicer enzymes from higher
eukaryotes. We choose this enzyme because it is easily
expressed and puriﬁed in recombinant form
(Supplementary Figure S2), is much less susceptible to
product inhibition than human Dicer (11), and accurately
cleaves dsRNA into small RNAs of deﬁned length (18).
Indeed, unlike the human enzyme, Giardia Dicer was able
to keep pace with transcription in vitro and converted es-
sentially all of the transcribed dsRNA into small RNAs
(Figure 1A). Furthermore, in contrast to bacterial RNase
III, the products of Giardia Dicer fell within a narrow size
range, with the vast majority of all the small RNAs
produced about 26nt in length. We also found that, like
T7 RNA polymerase (19), Giardia Dicer is not inhibited
by components from PCR and thus DNA templates for
transcription/dicing reactions may be taken directly from
PCRs without an impact on small RNA yield. The result is
a simple procedure that starts with PCR of a segment of a
target gene and leads to remarkably high yields of small
RNAs 25–27nt in length in just a few hours with very little
manual intervention (Figure 1B). At the end of the
reaction the DNA template can be degraded by adding
DNase I. For some templates we found that unprocessed
single-stranded RNA accumulated during transcription.
These RNAs can be degraded by the addition of RNase
T1 at the end of the reaction. Treatment with RNase T1
does not signiﬁcantly impact gene-silencing potency of the
small RNAs (data not shown). In our hands, a 100ml
reaction containing 3–5ml of a standard PCR and 2mg
of recombinant Giardia Dicer, was sufﬁcient to generate
20–100mg of small products in just a few hours.
Giardia Dicer products are substrates for human Dicer
The size of small RNAs generated by Giardia Dicer is
25–27nt (11), which is 4–6nt longer than traditional
21-nt siRNAs. In this respect, Giardia products resemble
commercially available synthetic 27 nucleotide RNAs
named ‘Dicer-substrate siRNAs’ (DsiRNAs) (20). We
therefore suspected that the small RNAs generated by
Giardia Dicer would serve as effective substrates for
cleavage by human Dicer. To test this idea directly, we
introduced an internal
32P-label into the RNA during
the co-transcriptional dicing reaction and used the
puriﬁed, radiolabeled small RNAs as substrates in a
cleavage reaction with recombinant human Dicer
(Figure 2). As predicted, human Dicer efﬁciently cleaved
PCR amplify target gene 
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    transcription components,
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and gene-specific primers
transcription template
transcription template +
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small RNA pool
35 nt –
21 nt –
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no RNase
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clean-up
  
Figure 1. Single pot reaction to generate small RNA pools. (A) Three
ribonucleases were tested for the ability to generate siRNA pools
during in vitro transcription. Reactions contained either 275ng/ul
human Dicer, 0.01 unit/ml ‘ShortCut’ RNase III, or 10ng/ml Giardia
Dicer. RNA products were resolved by denaturing PAGE and stained
with ethidium bromide. (B) Schematic of the optimized method for
producing small RNAs using Giardia Dicer.
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siRNAs, about 21nt in length. Therefore, upon introduc-
tion into mammalian cells Giardia Dicer products could
enter the RNAi pathway through the action of endogen-
ous human Dicer. Also, like commercially available
DsiRNAs, products of Giardia Dicer should be short
enough to avoid the interferon response (20).
Giardia Dicer products silence luciferase reporters in
mammalian cells
We next tested the ability of Giardia Dicer siRNA pools to
speciﬁcally silence a reporter gene when transfected into
mammalian cells. Giardia Dicer was used to generate small
RNAs against a 500bp segment of the ﬁreﬂy luciferase
gene. Various concentrations of the small RNAs were
transfected with ﬁxed amounts of ﬁreﬂy and Renilla
luciferase reporter plasmids into HEK 293 cells. Renilla
luciferase was included to normalize for transfection efﬁ-
ciency and also served as an indicator of non-speciﬁc gene
silencing. Transfecting 4.5nM Giardia Dicer small RNAs
silenced more than 95% of the co-transfected ﬁreﬂy
reporter compared to the no siRNA control
(Figure 3A). Increasing the concentration of small
RNAs to 45nM silenced >98% of the ﬁreﬂy luciferase,
with no appreciable effect on expression of Renilla. A pool
of siRNAs generated by recombinant human Dicer, using
the method of Myers et al. (2), produced a nearly identical
dose response (Figure 3A), revealing that small RNA
pools generated by Giardia Dicer have very similar
silencing potencies to siRNA pools made by human
Dicer. This observation is in contrast to the previous
report that 27-nt DsiRNAs are more efﬁcient at
inducing RNAi than 21nt siRNAs (20). Likewise, in a
separate experiment, small RNAs generated by human
Dicer, Giardia Dicer or RNase III gave rise to similar
levels of luciferase silencing when transfected into either
HeLa or HEK 293 cells (Figure 3B). Efﬁcient silencing of
ﬁreﬂy luciferase in NIH 3T3 cells (data not shown) also
demonstrated that Giardia Dicer products can induce
RNAi of a reporter gene in multiple mammalian cells
types. The combined results suggest that the small
RNAs produced by Giardia Dicer are functionally equiva-
lent to small silencing RNAs generated using previously
described methods.
Giardia Dicer products silence endogenous targets in
mammalian cells
Because Giardia Dicer siRNAs silence a reporter gene as
efﬁciently as other siRNA pools, we expected that they
Figure 3. Silencing of a luciferase reporter by Giardia Dicer products.
(A) HEK293 FT cells were transfected with ﬁreﬂy and Renilla luciferase
reporter plasmids and increasing concentrations of siRNA pools target-
ing ﬁreﬂy luciferase. Small RNA pools generated by either Giardia or
human Dicer enzymes were tested. Relative ﬁreﬂy luciferase activity
levels (normalized to Renilla levels) are plotted is as a function of
siRNA concentration. Data points are averages of three independent
measurements±standard deviation. (B) HEK 293 or HeLa cells were
transfected with ﬁreﬂy and Renilla luciferase reporters and siRNA
pools (200ng/ml; 12–15nM ﬁnal concentration) targeting ﬁreﬂy
luciferase that had been generated by human Dicer, Giardia Dicer, or
bacterial RNase III. Relative ﬁreﬂy activity levels are shown.
Figure 2. Giardia Dicer products are substrates for human Dicer.
Internally radiolabeled products of Giardia Dicer were incubated with
or without recombinant human Dicer, and then analyzed by denaturing
PAGE.
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gene. To test this idea we used Giardia Dicer to generate a
pool of small RNAs targeting protein phosphatase
methylesterase-1 (PME-1). Small RNAs were transfected
into HEK 293 cells (33nM ﬁnal concentration). After 48h
the cells were lysed and PME-1 levels were measured by
quantitative western blotting (Figure 4). Small RNA pools
against Renilla luciferase were transfected separately as a
negative control. The PME-1 small RNAs reduced the
amount of PME-1 in the crude cell lysate to 27% the
level of the negative control. Transfecting a validated syn-
thetic siRNA targeting PME-1 (21) at the same concen-
tration reduced the level of PME-1 by a similar amount
(Figure 4). These data demonstrate that, like conventional
siRNAs, small RNAs generated using Giardia Dicer in
transcription/dicing reactions can be used to knock-down
endogenous genes in mammalian cells.
CONCLUSION
We have tested the transcription/dicing reaction on a
variety of template sequences and found it to be a repro-
ducible and robust method for generating small RNA
pools (Supplementary Figure S3). However, it should be
noted that in some cases we observed the accumulation of
long, Dicer-resistant single stranded RNA species,
thought to arise from preferential transcription from one
DNA strand, which can promote toxicity or gene-silencing
artifacts when transfected into mammalian cells. In these
cases, it is important to include the RNase T1 digestion at
the end of the transcription/dicing reaction to degrade any
unprocessed single stranded RNA. We also found that
older preparations of Giardia Dicer had reduced enzymat-
ic activity, which can result in incomplete processing of
long dsRNA when used in the transcription/dicing
reaction. We found that Giardia Dicer stored in 50%
glycerol at  80 C remains active for 4–6 months
(storing at  20 C reduced its lifetime). Similarly, the com-
mercially available ‘PowerCut’ Giardia Dicer had lower
dicing activity than enzyme freshly prepared in house
(data not shown). In cases of low dicing activity, longer
reaction times (overnight at 37 C) often led to more
complete dsRNA cleavage. Furthermore, it is always
beneﬁcial to conﬁrm complete processing of long RNAs
in transcription/dicing reactions by denaturing PAGE in
order to avoid artifacts in downstream RNAi assays.
In summary, we have developed a simple and rapid
method for generating small RNA pools against any
target gene. The strengths of the procedure include low
cost of materials, technical simplicity and speed. We
imagine the method will be particularly beneﬁcial in situ-
ations in which several RNAi experiments would be in-
formative but allocated resources are limiting.
Furthermore, because the entire reaction can be carried
out in a single reaction tube this method could be
adapted to a high-throughput format and used for inex-
pensive large-scale RNAi screens.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–3.
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